pharmaceuticals
pharmaceuticals Articles
Syros Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
The annual meeting for ASCO is generally one of the biggest weeks of the year for the health care sector. However, there are inevitably winners and losers.
Published:
Last Updated:
A few biotech companies made fantastic runs in Thursday’s session. We have included information about each company, as well as recent trading activity and the consensus price target.
Published:
Last Updated:
A new study from IMS Health has projected that the global market for cancer treatments rose to $107 billion in 2015.
Published:
Last Updated:
Merrill Lynch is one of the major firms that will be in attendance at the American Society of Clinical Oncology (ASCO) annual meeting, and it has issued a report on what it is looking for.
Published:
Last Updated:
The American Society of Clinical Oncology (ASCO) is gearing up for its annual meeting. At this meeting, cancer drug developers will share the results from their most recent drug trials.
Published:
Last Updated:
Here are seven speculative biotech and biohealth players in which analyst calls during the week ending May 27 have given major upside projections.
Published:
Last Updated:
Shares of Titan Pharmaceuticals saw a handy gain early in Friday’s session following the U.S. Food and Drug Administration (FDA) approval of its partner’s opioid dependence treatment.
Published:
Last Updated:
These two biotech companies not only have data that could prove to be huge, but the stocks have been absolutely hammered over the past year, offering the best entry points in some time.
Published:
Last Updated:
Minerva Neurosciences saw its shares make absolutely massive gains on Thursday following the release of positive results from a couple mid-stage clinical trials.
Published:
Last Updated:
Ionis Pharmaceuticals shares dropped severely after a less-than positive update on its IONIS-TTR Rx program.
Published:
Last Updated:
Many companies are being discussed as Zika virus winners, but the reality is that many of them are so small or have sketchy histories. This is why we are featuring seven notable companies targeting...
Published:
Last Updated:
Selecta Biosciences has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Despite the ongoing political candidate chirping, all of these quality big pharmaceutical stocks have been around, and they will continue to stay around.
Published:
Last Updated:
24/7 Wall St. has collected several big FDA decisions and imminent clinical trial results that should be coming up in the June quarter. We have added some color.
Published:
Last Updated: